These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25743146)

  • 1. [Stevens-Johnson syndrome induced by regorafenib in a patient with progressive recurrent rectal carcinoma].
    Mihara Y; Yamaguchi K; Nakama T; Nakayama G; Kamei H; Ishibashi N; Uchida S; Akagi Y; Ogata Y
    Gan To Kagaku Ryoho; 2015 Feb; 42(2):233-6. PubMed ID: 25743146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of erythema multiforme induced by regorafenib therapy for metastatic colon cancer].
    Mii Y; Fukuoka E; Murata K; Otsubo D; Sawa H; Oka S; Iwatani Y; Kuroda D
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1841-3. PubMed ID: 25731348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of Recurrent Colorectal Cancer with Bilateral Ovarian Metastases That Were Reduced with Regorafenib Therapy].
    Nakae S; Nogi Y; Arima J; Okamoto D; Urakawa N; Fujikawa M; Gon H; Takebe A; Shinzeki M; Tanaka K; Senzaki H
    Gan To Kagaku Ryoho; 2017 Jul; 44(7):607-610. PubMed ID: 28790267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful Administration of Regorafenib to a Metastatic Colon Cancer Patient with Impaired Performance Status by Reducing the Initial Dose].
    Nishitai R; Manaka D; Kudo R; Mitsuoka E; Kanai S; Kanto S; Yoshino K; Hamasu SY; Konishi S; Yamashiro Y
    Gan To Kagaku Ryoho; 2015 Jul; 42(7):871-3. PubMed ID: 26197753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute liver failure and seizures as a consequence of regorafenib exposure in advanced rectal cancer.
    Raissouni S; Quraishi Z; Al-Ghamdi M; Monzon J; Tang P; Vickers MM
    BMC Res Notes; 2015 Oct; 8():538. PubMed ID: 26438070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regorafenib-induced hyperammonemic encephalopathy.
    Kuo JC; Parakh S; Yip D
    J Clin Pharm Ther; 2014 Aug; 39(4):446-8. PubMed ID: 24707992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tolerability and efficacy of regorafenib in patients with unresectable metastatic colorectal cancer].
    Tanaka A; Sadahiro S; Suzuki T; Okada K; Saito G
    Gan To Kagaku Ryoho; 2014 Oct; 41(10):1231-6. PubMed ID: 25335705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson syndrome induced by sorafenib for metastatic renal cell carcinoma.
    Ikeda M; Fujita T; Amoh Y; Mii S; Matsumoto K; Iwamura M
    Urol Int; 2013; 91(4):482-3. PubMed ID: 23969404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Patient with Cavitated Pulmonary Metastases Treated with Regorafenib].
    Taniguchi M; Mori M; Sata N; Fujii H
    Gan To Kagaku Ryoho; 2016 Jun; 43(6):757-9. PubMed ID: 27306815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Liver Failure Due to Regorafenib May Be Caused by Impaired Liver Blood Flow: A Case Report.
    Akamine T; Ando K; Oki E; Saeki H; Nakashima Y; Imamura YU; Ohgaki K; Maehara Y
    Anticancer Res; 2015 Jul; 35(7):4037-41. PubMed ID: 26124352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?].
    Schoeffler A; Levy E; Weinborn M; Cuny JF; Schmutz JL; Barbaud A; Cribier B; Bursztejn AC
    Ann Dermatol Venereol; 2014 Feb; 141(2):134-40. PubMed ID: 24507208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety study.
    Bruix J; Tak WY; Gasbarrini A; Santoro A; Colombo M; Lim HY; Mazzaferro V; Wiest R; Reig M; Wagner A; Bolondi L
    Eur J Cancer; 2013 Nov; 49(16):3412-9. PubMed ID: 23809766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse event management strategies: optimizing treatment with regorafenib in patients with metastatic colorectal cancer.
    Mitchell J; Khoukaz T; McNeal D; Brent L
    Clin J Oncol Nurs; 2014 Apr; 18(2):E19-25. PubMed ID: 24675266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible posterior leukoencephalopathy syndrome during regorafenib treatment: a case report and literature review of reversible posterior leukoencephalopathy syndrome associated with multikinase inhibitors.
    Myint ZW; Sen JM; Watts NL; Druzgal TJ; Nathan BR; Ward MD; Boyer JE; Fracasso PM
    Clin Colorectal Cancer; 2014 Jun; 13(2):127-30. PubMed ID: 24461491
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigation of Regorafenib-induced Hypothyroidism in Patients with Metastatic Colorectal Cancer.
    Sugita K; Kawakami K; Yokokawa T; Mae Y; Toya W; Hagino A; Suzuki K; Suenaga M; Mizunuma N; Yamaguchi T; Hama T
    Anticancer Res; 2015 Jul; 35(7):4059-62. PubMed ID: 26124355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial.
    Eisen T; Joensuu H; Nathan PD; Harper PG; Wojtukiewicz MZ; Nicholson S; Bahl A; Tomczak P; Pyrhonen S; Fife K; Bono P; Boxall J; Wagner A; Jeffers M; Lin T; Quinn DI
    Lancet Oncol; 2012 Oct; 13(10):1055-62. PubMed ID: 22959186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycoplasma pneumoniae-induced recurrent Stevens-Johnson syndrome in children: a case report.
    Campagna C; Tassinari D; Neri I; Bernardi F
    Pediatr Dermatol; 2013; 30(5):624-6. PubMed ID: 24016288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regorafenib in metastatic colorectal cancer.
    Grothey A
    Clin Adv Hematol Oncol; 2012 May; 10(5):324-5. PubMed ID: 22706543
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib.
    Wong AL; Lim JS; Sinha A; Gopinathan A; Lim R; Tan CS; Soh T; Venkatesh S; Titin C; Sapari NS; Lee SC; Yong WP; Tan DS; Pang B; Wang TT; Zee YK; Soong R; Trnkova Z; Lathia C; Thiery JP; Wilhelm S; Jeffers M; Goh BC
    J Transl Med; 2015 Feb; 13():57. PubMed ID: 25889309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of Administration Technique of Regorafenib in Our Center].
    Matsuda C; Danno K; Miyazaki S; Fujitani K; Kubota M; Motoori M; Nakatsuka R; Nishimura M; Kitagawa A; Takagi M; Iwase K
    Gan To Kagaku Ryoho; 2017 Jan; 44(1):47-51. PubMed ID: 28174379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.